Effects of Abiraterone Acetate on Chronic Kidney Disease in 2 Patients With Metastatic Castration-resistant Prostate Cancer

被引:4
作者
Francini, Edoardo [1 ]
Petrioli, Roberto [3 ]
Fiaschi, Anna Ida [2 ]
Laera, Letizia [3 ]
Roviello, Giandomenico [3 ]
机构
[1] Univ Rome, Policlin Umberto Hosp 1, Med Oncol Unit, Rome, Italy
[2] Univ Siena, Pharmacol Unit, I-53100 Siena, Italy
[3] Univ Siena, Med Oncol Unit, I-53100 Siena, Italy
关键词
INCREASED SURVIVAL; IMMUNOTHERAPY; MITOXANTRONE; PREDNISONE; CYP17;
D O I
10.1097/MD.0000000000000163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Prostate cancer is the second leading cause of cancer-related death in men in most Western countries. In this report, we present 2 cases of metastatic castration-resistant prostate cancer and chronic kidney disease. Both patients underwent and developed clinical resistance to androgen-deprivation therapy. Subsequently, the patients were treated with the conventional chemotherapeutic approach, which resulted in the worsening of renal function and performance status. Therefore, we opted for treatment with abiraterone acetate, and the patients exhibited improvements in renal function with good response of the disease.
引用
收藏
页数:3
相关论文
共 50 条
[41]   Activity of Cabazitaxel After Docetaxel and Abiraterone Acetate Therapy in Patients With Castration-Resistant Prostate Cancer [J].
Sella, Avishay ;
Sella, Tal ;
Peer, Avivit ;
Berger, Raanan ;
Frank, Stephen Jay ;
Gez, Eli ;
Sharide, David ;
Hayat, Henry ;
Hanovich, Ekaterina ;
Kovel, Svetlana ;
Rosenbaum, Eli ;
Neiman, Victoria ;
Keizman, Daniel .
CLINICAL GENITOURINARY CANCER, 2014, 12 (06) :428-432
[42]   A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy [J].
Satoh, Takefumi ;
Uemura, Hiroji ;
Tanabe, Kazunari ;
Nishiyama, Tsutomu ;
Terai, Akito ;
Yokomizo, Akira ;
Nakatani, Tatsuya ;
Imanaka, Keiichiro ;
Ozono, Seiichiro ;
Akaza, Hideyuki .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (12) :1206-1215
[43]   Abiraterone Acetate: Targeting Persistent Androgen Dependence in Castration-Resistant Prostate Cancer [J].
Harshman, Lauren C. ;
Taplin, Mary-Ellen .
ADVANCES IN THERAPY, 2013, 30 (08) :727-747
[44]   Abiraterone acetate plus prednisolone treatment beyond prostate specific antigen and radiographic progression in metastatic castration-resistant prostate cancer patients [J].
Biro, Krisztina ;
Budai, Barna ;
Szonyi, Marta ;
Kuronya, Zsofia ;
Gyergyay, Fruzsina ;
Nagyivanyi, Krisztian ;
Geczi, Lajos .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (02) :81.e1-81.e7
[45]   The changing landscape in metastatic castration-resistant prostate cancer [J].
Leibowitz-Amit, Raya ;
Joshua, Anthony M. .
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) :243-248
[46]   The Influence of Prior Abiraterone Treatment on the Clinical Activity of Docetaxel in Men with Metastatic Castration-resistant Prostate Cancer [J].
Schweizer, Michael T. ;
Zhou, Xian C. ;
Wang, Hao ;
Bassi, Sunakshi ;
Carducci, Michael A. ;
Eisenberger, Mario A. ;
Antonarakis, Emmanuel S. .
EUROPEAN UROLOGY, 2014, 66 (04) :646-652
[47]   Beyond abiraterone New hormonal therapies for metastatic castration-resistant prostate cancer [J].
Pinto, Alvaro .
CANCER BIOLOGY & THERAPY, 2014, 15 (02) :149-155
[48]   Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone [J].
Schrader, Andres Jan ;
Boegemann, Martin ;
Ohlmann, Carsten-H. ;
Schnoeller, Thomas J. ;
Krabbe, Laura-Maria ;
Hajili, Turkan ;
Jentzmik, Florian ;
Stoeckle, Michael ;
Schrader, Mark ;
Herrmann, Edwin ;
Cronauer, Marcus V. .
EUROPEAN UROLOGY, 2014, 65 (01) :30-36
[49]   Response to Subsequent Docetaxel in a Patient Cohort With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Acetate Treatment [J].
Aggarwal, Rahul ;
Harris, Anna ;
Formaker, Carl ;
Small, Eric J. ;
Molina, Arturo ;
Griffin, Thomas W. ;
Ryan, Charles J. .
CLINICAL GENITOURINARY CANCER, 2014, 12 (05) :E167-E172
[50]   Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy [J].
Harland, Stephen ;
Staffurth, John ;
Molina, Arturo ;
Hao, Yanni ;
Gagnon, Dennis D. ;
Sternberg, Cora N. ;
Cella, David ;
Fizazi, Karim ;
Logothetis, Christopher J. ;
Kheoh, Thian ;
Haqq, Christopher M. ;
de Bono, Johann S. ;
Scher, Howard I. .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (17) :3648-3657